Iva Mucalo

Prof. Iva Mucalo

Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2014 in Journal of the American Society of Hypertension
Verified
Journal Article
Closed access
EJElena Jovanovski
Elena Jovanovski
EBEmma A. Bateman
Emma A. Bateman
JBJyoti Bhardwaj
Jyoti Bhardwaj
CFChris Fairgrieve
Chris Fairgrieve
IMIva Mucalo
Iva Mucalo
Vladimir VuksanVladimir Vuksan
Vladimir Vuksan

1 October 2013 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
IMIva Mucalo
Iva Mucalo
EJElena Jovanovski
Elena Jovanovski
DRDario Rahelić
Dario Rahelić
VBVelimir Božikov
Velimir Božikov
ŽRŽeljko Romić
Željko Romić
Vladimir VuksanVladimir Vuksan
Vladimir Vuksan

12 April 2017 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
IMIva Mucalo
Iva Mucalo
MHMaja Ortner Hadžiabdić
Maja Ortner Hadžiabdić
ABAndrea Brajković
Andrea Brajković
SLSonja Lukić
Sonja Lukić
PMPatricia Marić
Patricia Marić
VBVesna Bačić-Vrca
Vesna Bačić-Vrca

11 December 2018 in BMC Medical Education
Verified
Journal Article
Open access
PDF file
MDMargita Držaić
Margita Držaić
IKIngrid Kummer
Ingrid Kummer
IMIva Mucalo
Iva Mucalo
ABAndreia Bruno-Tome
Andreia Bruno-Tome
MHMaja Ortner Hadžiabdić
Maja Ortner Hadžiabdić
Competency frameworks that prompt personal and professional development have become an important component of lifelong learning; they are driven by healthcare professionals’ need for development and professional recognition. This study aimed to evaluate the self-assessed competencies of community pharmacist-preceptors by using Croatian Competency Framework (CCF) and to identify competencies to be improved. The secondary aim was to explore the association between community pharmacists’ characteristics (i.e. age, education etc.) and self-assessed competency performance. The study subjects were community pharmacist-preceptors who provide support to and mentor student trainees enrolled in pre-registration training for pharmacy students. At the beginning of their mentorship, the pharmacist-preceptors assessed their competencies on a four-point Likert scale by using the Croatian Competency Framework (CCF), a validated tool for assessment and self-assessment of community and hospital pharmacists. Data were collected via e-mail in the period from October 2015 to April 2016. Of the 260 community pharmacists approached, final analysis included 223 respondents. The response rate was 85.8%. Community pharmacist-preceptors assessed themselves as the most competent in competencies pertaining to the cluster “Organization and management competencies” (M = 3.64, SD = 0.34), while they considered themselves as the least competent in the competencies pertaining to the cluster “Pharmaceutical public health competencies” (M = 2.75, SD = 0.77). Younger pharmacists with a postgraduate qualification who worked for large pharmacy chains in the capital city area and who had been in their current posts for a shorter period perceived themselves to be more competent. This research represents the first analysis of the CCF in practice and identifies community pharmacist-preceptor competencies that require improvement. Consequently, areas for additional professional education were defined. Implementing modalities to measure and support development of preceptors’ competences is essential for improvement of student training programmes.

1 October 2016 in American Journal of Pharmaceutical Education
Verified
Journal Article
Open access
PDF file
IMIva Mucalo
Iva Mucalo
MHMaja Ortner Hadžiabdić
Maja Ortner Hadžiabdić
TGTihana Govorčinović
Tihana Govorčinović
MŠMartina Šarić
Martina Šarić
ABAndreia Bruno
Andreia Bruno
IBIan Bates
Ian Bates
Objective. To adjust and validate the Global Competency Framework (GbCF) to be relevant for Croatian community and hospital pharmacists. Methods. A descriptive study was conducted in three steps: translation, consensus development, and validation by an expert panel and public consultation. Panel members were representatives from community pharmacies, hospital pharmacies, regulatory and professional bodies, academia, and industry. Results. The adapted framework consists of 96 behavioral statements organized in four clusters: Pharmaceutical Public Health, Pharmaceutical Care, Organization and Management, and Personal and Professional Competencies. When mapped against the 100 statements listed in the GbCF, 27 matched, 39 were revised, 30 were introduced, and 24 were excluded from the original framework. Conclusions. The adaptation and validation proved that GbCF is adaptable to local needs, the Croatian Competency Framework that emerged from it being an example. Key amendments were made within Organization and Management and Pharmaceutical Care clusters, demonstrating that these issues can be country specific.

1 January 2014 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
IMIva Mucalo
Iva Mucalo
EJElena Jovanovski
Elena Jovanovski
Vladimir VuksanVladimir Vuksan
Vladimir Vuksan
VBVelimir Božikov
Velimir Božikov
ŽRŽeljko Romić
Željko Romić
DRDario Rahelić
Dario Rahelić
Aim. The objective of the present study was to test the safety of supplementation with the American ginseng (AG) interventional material as an adjunct to conventional therapy (diet and/or medications) in type 2 diabetes, using a double‐blind, randomized, placebo‐controlled, parallel design. Methods. Each participant received either AG (10% ginsenosides) or placebo capsules (500 mg/meal = 3 g/day) for a period of 12 weeks. Outcomes included measures of safety including kidney function (urates and creatinine), liver function (AST and ALT), and haemostatic function (PV and INR). Results. Seventy‐four participants with well‐controlled type 2 diabetes (sex: 28 M and 46 F, age: 63 ± 9.5, BMI: 32 ± 5, and HbA1c: 7 ± 1.3), randomized to either intervention (n = 35) or control (n = 39) group, completed the study. There was no change in any of the measures of safety between treatments from baseline. The number or severity of adverse events did not differ between the AG intervention and placebo. Conclusion. Following 12 weeks of supplementation with AG, safety was not compromised in a high cardiovascular disease (CVD) risk population of patients with type 2 diabetes. This demonstrated that safety is noteworthy, as reviews have continuously warned of possible adverse effects of ginseng consumption.